0000947871-23-000336.txt : 20230317 0000947871-23-000336.hdr.sgml : 20230317 20230317162956 ACCESSION NUMBER: 0000947871-23-000336 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230227 FILED AS OF DATE: 20230317 DATE AS OF CHANGE: 20230317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORDON CARL L CENTRAL INDEX KEY: 0001282930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38762 FILM NUMBER: 23743027 MAIL ADDRESS: STREET 1: 601 LEXINGTON AVENUE STREET 2: 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OrbiMed Israel GP Ltd. CENTRAL INDEX KEY: 0001569590 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38762 FILM NUMBER: 23743028 BUSINESS ADDRESS: STREET 1: 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR CITY: HERZLIYA STATE: L3 ZIP: 46766 BUSINESS PHONE: 212-739-6400 MAIL ADDRESS: STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022-4629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OrbiMed Israel BioFund GP Limited Partnership CENTRAL INDEX KEY: 0001569821 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38762 FILM NUMBER: 23743029 BUSINESS ADDRESS: STREET 1: 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR CITY: HERZLIYA STATE: L3 ZIP: 46766 BUSINESS PHONE: 212-739-6400 MAIL ADDRESS: STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 1022-4629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chimovits Erez CENTRAL INDEX KEY: 0001706399 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38762 FILM NUMBER: 23743026 MAIL ADDRESS: STREET 1: P.O. BOX 4023 CITY: HERZLIYA PITUACH STATE: L3 ZIP: 4614001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BiomX Inc. CENTRAL INDEX KEY: 0001739174 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 EINSTEIN ST., 4TH FLOOR CITY: NESS ZIONA STATE: L3 ZIP: 7414003 BUSINESS PHONE: (972) 72 394 2377 MAIL ADDRESS: STREET 1: 22 EINSTEIN ST., 4TH FLOOR CITY: NESS ZIONA STATE: L3 ZIP: 7414003 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20180430 4 1 ownership.xml X0306 4 2023-02-27 0 0001739174 BiomX Inc. PHGE 0001569821 OrbiMed Israel BioFund GP Limited Partnership 5 HAHOSHLIM STREET, BUILDING B, 1ST FL. HERZLIYA PITUACH L3 46686 ISRAEL 0 0 1 0 0001569590 OrbiMed Israel GP Ltd. 5 HAHOSHLIM STREET, BUILDING B, 1ST FL. HERZLIYA PITUACH L3 46686 ISRAEL 0 0 1 0 0001282930 GORDON CARL L C/O ORBIMED ISRAEL GP LTD. 5 HAHOSHLIM STREET, BUILDING B, 1ST FL. HERZLIYA PITUACH L3 46686 ISRAEL 0 0 1 0 0001706399 Chimovits Erez C/O ORBIMED ISRAEL GP LTD. 5 HAHOSHLIM STREET, BUILDING B, 1ST FL. HERZLIYA PITUACH L3 46686 ISRAEL 0 0 1 0 Common Stock 2023-02-27 4 P 0 348000 0.245 A 3161489 I See Footnotes Warrants (Right to Buy) 0.244 2023-02-27 4 P 0 1789959 A 2023-02-27 2033-02-27 Common Stock 1789959 1789959 I See Footnotes These shares of the Issuer's common stock and warrants to purchase shares of the Issuer's common stock were purchased from the Issuer in a private placement. The warrants are exercisable for one share of the Issuer's common stock per warrant, subject to an issuance limitation that prohibits the holder from exercising the warrants to the extent that after giving effect to such issuance after exercise, the holder (together with the holder's affiliates and any other persons acting as a group together with the holder or any of the holder's affiliates, including the Reporting Persons) would beneficially own in excess of 9.99% of the shares of common stock outstanding immediately after giving effect to the issuance of the shares of common stock issuance upon exercise of the warrants. These securities are held of record by OrbiMed Israel Partners Limited Partnership ("OIP"). OrbiMed Israel BioFund GP Limited Partnership ("OrbiMed BioFund") is the general partner of OIP and OrbiMed Israel GP Ltd. ("OrbiMed Israel") is the general partner of OrbiMed BioFund. By virtue of such relationships, OrbiMed Israel and OrbiMed BioFund may be deemed to have voting and investment power over the securities held by OIP and, as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Israel exercises investment and voting power through an investment committee comprised of Carl L. Gordon and Erez Chimovits. Each of OrbiMed Israel, OrbiMed BioFund, Carl Gordon, and Erez Chimovits disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. OrbiMed Israel GP Ltd., By: /s/ Douglas Coon, Chief Compliance Officer 2023-03-17 OrbiMed Israel BioFund GP Limited Partnership, By: /s/ Douglas Coon, Chief Compliance Officer 2023-03-17 /s/ Carl L. Gordon 2023-03-17 /s/ Erez Chimovits 2023-03-17